Search Results - "Grate, Lisa"
-
1
A retrospective review of fall risk factors in the bone marrow transplant inpatient service
Published in Journal of oncology pharmacy practice (01-06-2018)“…Purpose The purpose of this study was to compare medications and potential risk factors between patients who experienced a fall during hospitalization compared…”
Get full text
Journal Article -
2
Comparison of incidence of hypersensitivity reactions of paclitaxel infusions with titrated versus non-titrated infusions
Published in Gynecologic oncology (01-08-2021)“…Determine the incidence of infusion reactions in the first and second cycles for patients with titrated paclitaxel infusion. A retrospective chart review was…”
Get full text
Journal Article -
3
Association of tumor infiltrating lymphocytes with pathological response after neoadjuvant therapy in breast cancer: A retrospective study
Published in Journal of clinical oncology (20-05-2021)“…Abstract only e12621 Background: Tumor infiltrating lymphocytes (TILs) are thought to represent favorable host anti-tumor immunity and play an important role…”
Get full text
Journal Article -
4
Retrospective, cohort study evaluating empiric dose-reduced nab-paclitaxel with gemcitabine in metastatic pancreatic adenocarcinoma: A single institution experience
Published in Journal of clinical oncology (01-02-2019)“…Abstract only 456 Background: The phase III MPACT trial was conducted to assess OS in patients with metastatic pancreatic adenocarcinoma (mPAC) receiving…”
Get full text
Journal Article -
5
Abstract PS14-02: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Abstract Title: Real-world analysis comparing Black and White patients with triple-negative breast cancer receiving therapy per KEYNOTE-522 Background:…”
Get full text
Journal Article -
6
Abstract PS14-06: Real-World Analysis of Adverse Events in Patients with Triple Negative Breast Cancer Receiving Therapy per KEYNOTE-522
Published in Cancer research (Chicago, Ill.) (02-05-2024)“…Title: Real-world analysis of adverse events in patients with triple-negative breast cancer receiving therapy per KEYNOTE-522 Background: KEYNOTE-522 was a…”
Get full text
Journal Article